ChosenMed Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

ChosenMed General Information

Description

Manufacturer of precision oncology diagnostic kits designed to enable accurate tumour detection and personalised cancer treatment. The company offers multi-gene companion diagnostic assays, tumor gene testing panels and early cancer screening products across solid tumors and hematologic malignancies, enabling hospitals, oncology laboratories and cancer specialists, to conduct precise molecular diagnostics and guide targeted therapeutic decisions.

Contact Information

Formerly Known As
Qiuzhen Medical Technology (Beijing)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 156, Jinghai Fourth Road, Beijing Economic and Technological Development Area
  • Donghu Street, Linping District, Hangzhou City, Jinghai Industrial Park
  • Beijing, Zhejiang 100176
  • China
+86 010
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • Number 156, Jinghai Fourth Road, Beijing Economic and Technological Development Area
  • Donghu Street, Linping District, Hangzhou City, Jinghai Industrial Park
  • Beijing, Zhejiang 100176
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChosenMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 24-Oct-2024 Completed Generating Revenue
9. Later Stage VC 22-Mar-2023 Completed Generating Revenue
8. Later Stage VC (Series C2) 20-Dec-2021 Completed Generating Revenue
7. Secondary Transaction - Private 17-Dec-2021 Completed Generating Revenue
6. Later Stage VC (Series C1) 08-Oct-2021 Completed Generating Revenue
5. Early Stage VC 27-Jul-2020 Completed Generating Revenue
4. Secondary Transaction - Private 15-Mar-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 15-Mar-2020 Completed Product In Beta Test
2. Early Stage VC 14-May-2018 Completed Product In Beta Test
1. Early Stage VC (Series A) 18-Mar-2018 Completed Product In Beta Test
To view ChosenMed’s complete valuation and funding history, request access »

ChosenMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChosenMed Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gandao Investment Holding Company Asset Manager Minority
Dezhou Financial Investment Growth/Expansion Minority
Hangzhou Linzhuo Industry Investment Government Minority
Hunan High-Tech Investment Group Venture Capital Minority
Jingming Innovation Capital Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

ChosenMed Investments (1)

ChosenMed’s most recent deal was a Seed Round with Xinchuan Biotechnology for . The deal was made on 28-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xinchuan Biotechnology 28-Mar-2022 Seed Round Drug Discovery
To view ChosenMed’s complete investments history, request access »

ChosenMed FAQs

  • When was ChosenMed founded?

    ChosenMed was founded in 2017.

  • Where is ChosenMed headquartered?

    ChosenMed is headquartered in Beijing, China.

  • What is the size of ChosenMed?

    ChosenMed has 17 total employees.

  • What industry is ChosenMed in?

    ChosenMed’s primary industry is Diagnostic Equipment.

  • Is ChosenMed a private or public company?

    ChosenMed is a Private company.

  • What is ChosenMed’s current revenue?

    The current revenue for ChosenMed is .

  • How much funding has ChosenMed raised over time?

    ChosenMed has raised $78M.

  • Who are ChosenMed’s investors?

    Gandao Investment Holding Company, Dezhou Financial Investment, Hangzhou Linzhuo Industry Investment, Hunan High-Tech Investment Group, and Jingming Innovation Capital are 5 of 14 investors who have invested in ChosenMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process